S&P Global Ratings on Monday said several Asia-Pacific economies could face higher tariffs under the Trump administration, ...

India's equity benchmark indices Sensex and Nifty experienced a significant drop in their early trade on Monday (24 February) ...

World shares experienced mixed results on Monday as US stocks fell sharply due to concerns over Trump's policies affecting ...

India's GDP may be impacted by proposed US tariffs raising by an estimated 0.1 to 0.6 percentage points, as per Goldman Sachs ...

India and Japan have a unique opportunity to gain from US tariffs, says Hero Enterprises' Sunil Kant Munjal. He believes ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...

Indian shares opened lower on Monday, mirroring global peers, as concerns over slowing U.S. growth added to the ongoing ...

Subhash Chand Aggarwal, Chairman & Managing Director, SMC Global Securities Limited, said that stable economic growth, ...

S&P Global Ratings reports that India, South Korea, and Thailand are most at risk of facing higher US tariffs under the Trump ...

The India-US ties will depend on India's readiness to be a willing partner in the American designs on China and what it will ...

Indian indices Sensex and Nifty opened lower, mirroring global market downturn fueled by US inflation concerns and FII ...

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...